Xiaohua Long

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 5

Top Topics

Stem Cell Transplantation

Helicobacter Pylori

Top Venues

Alimentary pharmacology & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Yu Huang, Huiyi Li, Xiaohua Long, Xiao Liang, Hong Lu
Lessons learned from upper gastrointestinal endoscopy in asymptomatic Chinese. Helicobacter 26 (3) (2021)
Lou Yu, Laisheng Luo, Xiaohua Long, Xiao Liang, Yingjie Ji, David Yates Graham, Hong Lu
High-dose PPI-amoxicillin dual therapy with or without bismuth for first-line Helicobacter pylori therapy: A randomized trial. Helicobacter 24 (4) (2019)
Qi Chen, Xiaohua Long, Yingjie Ji, Xiao Liang, Dongping Li, Hong Gao, Beili Xu, Ming Liu, Ying Chen, Yunwei Sun, Yan Zhao, Gang Xu, Yanyan Song, Lou Yu, Wei Zhang, Wenzhong Liu, David Yates Graham, Hong Lu
Randomised controlled trial: susceptibility-guided therapy versus empiric bismuth quadruple therapy for first-line Helicobacter pylori treatment. Alimentary pharmacology & therapeutics 49 (11) (2019)
Qi Chen, Xiao Liang, Xiaohua Long, Lou Yu, Wenzhong Liu, Hong Lu
Cost-effectiveness analysis of screen-and-treat strategy in asymptomatic Chinese for preventing Helicobacter pylori-associated diseases. Helicobacter 24 (2) (2019)
Xiaohua Long, Qi Chen, Lou Yu, Xiao Liang, Wenzhong Liu, Hong Lu
Bismuth improves efficacy of proton-pump inhibitor clarithromycin, metronidazole triple Helicobacter pylori therapy despite a high prevalence of antimicrobial resistance. Helicobacter 23 (3) (2018)